Dentsply Sirona Inc (XRAY)

Vienna


	Symbol		Exchange		Currency
	XRAY		NASDAQ		USD	Real-time
	0I8F		London		USD	Real-time
	1XRAY		Milan		EUR	Real-time
	DY2		TradeGate		EUR	Delayed
	DY2		Frankfurt		EUR	Delayed
	XRAY		Vienna		EUR	Real-time

Currency in EUR

Disclaimer

22.490

0.000(0.00%)

Real-time Data09/10

Fair Value

Day's Range

22.160

22.490

52 wk Range

21.640

34.140

Dentsply (XRAY) Income Statement & Profits

Assess the Dentsply Income Statement (earnings report), showing the company's financial performance from operating and non operating activities such as revenue, expenses and income. Check assets and liabilities, diluted earnings per share (EPS), and net income after taxes for the last 4 periods (either quarterly or annually).

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

4,022

3,339

4,231

3,922

3,965

Total Revenues Growth

+0.9%

-16.98%

+26.71%

-7.3%

+1.1%

Cost Of Revenues

1,833

1,639

1,887

1,795

1,875

Gross Profit

2,189

1,700

2,344

2,127

2,090

Gross Profit Growth

+4.79%

-22.34%

+37.88%

-9.26%

-1.74%

Gross Profit Margin %

54.43%

50.91%

55.4%

54.23%

52.71%

Other Operating Expenses, Total

1,721

1,432

1,718

1,770

1,801

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-1.83%	-16.79%	+19.97%	+3.03%	+1.75%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	143	123	171	174	184
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,578	1,309	1,547	1,596	1,617
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

468

268

626

357

289

Operating Income Growth

+39.29%

-42.74%

+133.58%

-42.97%

-19.05%

EBIT Margin %

11.64%

8.03%

14.8%

9.1%

7.29%

Net Interest Expenses

-27

-46

-61

-65

-81

Net Interest Expenses Growth

+22.86%

-70.37%

-32.61%

-6.56%

-24.62%

Interest Expense, Total

-27

-46

-64

-76

-97

Interest And Investment Income

-

-

3

11

16

Other Non Operating Expenses, Total

16

8

5

-43

-2

EBT, Excl. Unusual Items

457

230

570

249

206

Gain (Loss) On Sale Of Assets

9

-

3

-3

-

Other Unusual Items, Total

-

-123

-

-100

-16

EBT, Incl. Unusual Items

338

-50

545

-1,055

-175

EBT, Incl. Unusual Items Growth

+135.28%

-114.79%

+1,190%

-293.58%

+83.41%

EBT, Incl. Unusual Items Margin

8.4%

-1.5%

12.88%

-26.9%

-4.41%

Income Tax Expense

82

23

134

-105

-43

Net Income to Company

256

-73

411

-950

-132

Minority Interest

-

-

-

-

-

Net Income

256

-73

411

-950

-132

Net Income Growth

+125.32%

-128.52%

+663.01%

-331.14%

+86.11%

Net Income Margin %

6.36%

-2.19%

9.71%

-24.22%

-3.33%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

256

-73

411

-950

-132

Basic EPS - Continuing Operations

1.15

-0.33

1.88

-4.41

-0.62

Basic EPS - Continuing Operations Growth

+125.46%

-129.02%

+665.08%

-334.25%

+85.88%

Diluted EPS - Continuing Operations

1.14

-0.33

1.87

-4.41

-0.62

Diluted EPS - Continuing Operations Growth

+125.28%

-129.21%

+661.51%

-335.83%

+85.88%

Basic Weighted Average Shares Outstanding

223.1

219.2

218.4

215.5

212

Diluted Weighted Average Shares Outstanding

224.4

219.2

220.2

215.5

212

Dividend Per Share

0.38

0.4

0.43

0.5

0.56

Dividend Per Share Growth

+8.57%

+5.26%

+7.5%

+16.28%

+12%

EBITDA

788

588

972

685

632

EBITDA Growth

+18.14%

-25.38%

+65.31%

-29.53%

-7.74%

EBITDA Margin %